Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors

The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defined herein. The invention also provides pharmaceutical compositions comprising such compo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Otte Ryan D, Ellis John Michael, Andresen Brian M, Robichaud Joel S, Arrington Kenneth L, Northrup Alan B, Gauthier Jacques Yves, Fournier Jean-Francois, Butcher John W
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Otte Ryan D
Ellis John Michael
Andresen Brian M
Robichaud Joel S
Arrington Kenneth L
Northrup Alan B
Gauthier Jacques Yves
Fournier Jean-Francois
Butcher John W
description The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9822107B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9822107B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9822107B23</originalsourceid><addsrcrecordid>eNqNyrEOAUEQBuBtFIJ3mBe4hFWgJUS0Tn2Z45edWLubnbniPL3GA6i-5pu6SxuEPzmi0aFXExsMD-K3pBxgqJnrGJVYSUsEEtlYs0oCvSSxgiQF6cVy1bmbPDkqFj9njk7H9nBuUHIHLXxHgnW3627r_Wq52fv1H-ULcDs2Pg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors</title><source>esp@cenet</source><creator>Otte Ryan D ; Ellis John Michael ; Andresen Brian M ; Robichaud Joel S ; Arrington Kenneth L ; Northrup Alan B ; Gauthier Jacques Yves ; Fournier Jean-Francois ; Butcher John W</creator><creatorcontrib>Otte Ryan D ; Ellis John Michael ; Andresen Brian M ; Robichaud Joel S ; Arrington Kenneth L ; Northrup Alan B ; Gauthier Jacques Yves ; Fournier Jean-Francois ; Butcher John W</creatorcontrib><description>The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171121&amp;DB=EPODOC&amp;CC=US&amp;NR=9822107B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171121&amp;DB=EPODOC&amp;CC=US&amp;NR=9822107B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Otte Ryan D</creatorcontrib><creatorcontrib>Ellis John Michael</creatorcontrib><creatorcontrib>Andresen Brian M</creatorcontrib><creatorcontrib>Robichaud Joel S</creatorcontrib><creatorcontrib>Arrington Kenneth L</creatorcontrib><creatorcontrib>Northrup Alan B</creatorcontrib><creatorcontrib>Gauthier Jacques Yves</creatorcontrib><creatorcontrib>Fournier Jean-Francois</creatorcontrib><creatorcontrib>Butcher John W</creatorcontrib><title>Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors</title><description>The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEOAUEQBuBtFIJ3mBe4hFWgJUS0Tn2Z45edWLubnbniPL3GA6i-5pu6SxuEPzmi0aFXExsMD-K3pBxgqJnrGJVYSUsEEtlYs0oCvSSxgiQF6cVy1bmbPDkqFj9njk7H9nBuUHIHLXxHgnW3627r_Wq52fv1H-ULcDs2Pg</recordid><startdate>20171121</startdate><enddate>20171121</enddate><creator>Otte Ryan D</creator><creator>Ellis John Michael</creator><creator>Andresen Brian M</creator><creator>Robichaud Joel S</creator><creator>Arrington Kenneth L</creator><creator>Northrup Alan B</creator><creator>Gauthier Jacques Yves</creator><creator>Fournier Jean-Francois</creator><creator>Butcher John W</creator><scope>EVB</scope></search><sort><creationdate>20171121</creationdate><title>Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors</title><author>Otte Ryan D ; Ellis John Michael ; Andresen Brian M ; Robichaud Joel S ; Arrington Kenneth L ; Northrup Alan B ; Gauthier Jacques Yves ; Fournier Jean-Francois ; Butcher John W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9822107B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Otte Ryan D</creatorcontrib><creatorcontrib>Ellis John Michael</creatorcontrib><creatorcontrib>Andresen Brian M</creatorcontrib><creatorcontrib>Robichaud Joel S</creatorcontrib><creatorcontrib>Arrington Kenneth L</creatorcontrib><creatorcontrib>Northrup Alan B</creatorcontrib><creatorcontrib>Gauthier Jacques Yves</creatorcontrib><creatorcontrib>Fournier Jean-Francois</creatorcontrib><creatorcontrib>Butcher John W</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Otte Ryan D</au><au>Ellis John Michael</au><au>Andresen Brian M</au><au>Robichaud Joel S</au><au>Arrington Kenneth L</au><au>Northrup Alan B</au><au>Gauthier Jacques Yves</au><au>Fournier Jean-Francois</au><au>Butcher John W</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors</title><date>2017-11-21</date><risdate>2017</risdate><abstract>The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9822107B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Otte%20Ryan%20D&rft.date=2017-11-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9822107B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true